Aldosterone deficiency II (CMO II deficiency) is not the result of a mutation of an MspI restriction site within the CYP11B gene.

Abstract excerpt

We report our investigations of a German family with aldosterone deficiency (CMO II deficiency). Restriction fragment length polymorphism analysis using a P450c11 probe demonstrates that a MspI restriction site mutation within the CYP11B gene cannot be the underlying cause for this defect, as has been suggested previously.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoradiography
• Share to Blotting, Southern
• Share to Deoxyribonuclease HpaII